• Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio | Morningstar

    Source: Buzz FX / 27 Jan 2025 06:57:30   America/Chicago


    Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio
    NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp.
    Read more...
Share on,